Drugs / Vitamin C
Vitamin C
also known as
ascorbic acid · ascorbate · vit-C · IVC · L-ascorbic acid · polyethylene glycol + ascorbic acid · ASC · ASCOR · +14 more
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | BEROCCA PN | — | 1947-07-28 | fda.gov ↗ |
Trials 279 · started per year
today
US approved 1947
1
1
2
2
1
2
2
1
3
4
7
7
5
7
5
3
8
8
6
5
11
11
13
28
27
21
12
15
17
14
13
10
1
1946194719481949195019511952195319541955195619571958195919601961196219631964196519661967196819691970197119721973197419751976197719781979198019811982198319841985198619871988198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027202820292030
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 015 trials · 1 missed | ||||||
| Phase 0 | NCT06710899 | Jan → Aug 2027 expected | urinary tract infection | University Hospitals of North Midlands NHS Trust | Not yet recruiting | No outcome recorded |
| Phase 0 | NCT07197749 | Nov 2026 → Oct 2028 expected | acute graft versus host disease | Baylor College of Medicine | Not yet recruiting | No outcome recorded |
| Phase 0 | NCT07715669 | Aug 2026 → Mar 2027 expected | preeclampsia | Anna Stanhewicz, PhD | Recruiting | No outcome recorded |
| Phase 0 | NCT05932511 | Jun 2023 → Dec 2024 | skin carcinoma, squamous cell carcinoma | Center for Biomedical Research, Inc. | Unknown | No outcome recorded |
| Phase 0 | NCT04832009 | May 2022 → Aug 2026 overdue | hypertensive disorder | University of Kansas Medical Center | Recruiting | No outcome recorded |
| Phase 0 | NCT04261036 | Jul 2019 → Jul 2021 | — | American University of Beirut Medical Center | Withdrawn | No outcome recorded Stop: Enrollment |
| Phase 0 | NCT03744702 | Jun 2019 → Feb 2021 | vascular disorder | Mayo Clinic | Completed | No outcome recorded |
| Phase 0 | NCT04001647 | Jun 2019 → Aug 2022 | arterial disorder, isoproterenol-mediated vasodilatation | Colorado State University | Terminated | No outcome recorded |
| Phase 0 | NCT05009355 | Jan 2019 → Sep 2021 | vitamin deficiency disorder | Cairo University | Unknown | No outcome recorded |
| Phase 0 | NCT03756727 | Dec 2018 → May 2019 | — | Xuzhou Medical University | Unknown | No outcome recorded |
| Phase 0 | NCT03800667 | Aug 2018 → Jul 2019 | — | American University of Beirut Medical Center | Withdrawn | No outcome recorded Stop: Business |
| Phase 0 | NCT04279535 | Mar 2018 → Mar 2019 | basal cell carcinoma | Center for Biomedical Research, Inc. | Completed | No outcome recorded |
| Phase 0 | NCT02896907 | Oct 2016 → Mar 2018 | pancreatic adenocarcinoma | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Completed | No outcome recorded |
| Phase 0 | NCT00860743 | Sep 2009 → Sep 2013 | sleep apnea syndrome | VA Office of Research and Development | Completed | No outcome recorded |
| Phase 0 | NCT01017796 | Jan 2009 → Jan 2010 | acute tubulointerstitial nephritis | University of Thessaly | Unknown | Missed primary |
| Phase 128 trials · 1 missed | ||||||
| Phase 1 | NCT07612345 | Jul 2026 → Jul 2027 expected | G6PD deficiency, pyruvate kinase deficiency of red cells | University of Utah | Not yet recruiting | No outcome recorded |
| Phase 1 | NCT07121036 | Mar 2025 → Dec 2026 expected | scurvy | Zhongnan Hospital | Recruiting | No outcome recorded |
| Phase 1 | NCT06847880 | Feb 2025 → Feb 2026 | root resorption | University of Baghdad | Completed | No outcome recorded |
| Phase 1 | NCT06313502 | Jul 2024 → Apr 2027 expected | plasma cell neoplasm | University of Arkansas | Recruiting | No outcome recorded |
| Phase 1 | NCT05658029 | May → Sep 2023 | tracheal disorder | Matthew Bruehl | Withdrawn | No outcome recorded Stop: Enrollment |
| Phase 1 | NCT05215743 | Aug → Nov 2022 | acute myocardial infarction, ischemic disease | University of Chile | Completed | No outcome recorded |
| Phase 1 | NCT04150042 | Jan 2021 → Dec 2028 expected | BRCA1-related cancer predisposition, BRCA2-related cancer predisposition, Her2-receptor negative breast cancer, PALB2-related cancer predisposition +3 | General Oncology, Inc. | Recruiting | No outcome recorded |
| Phase 1 | NCT03066115 | Dec 2020 → Dec 2021 | — | University of Wisconsin, Madison | Withdrawn | No outcome recorded Stop: Enrollment |
| Phase 1 | NCT04370288 | Apr → Sep 2020 | COVID-19 | Mashhad University of Medical Sciences | Unknown | No outcome recorded |
| Phase 1 | NCT03684213 | Oct 2018 → May 2024 | cardiovascular disorder | The University of Texas at Arlington | Completed | No outcome recorded |
| Phase 1 | NCT03451266 | Apr 2018 → Jun 2019 | severe pre-eclampsia | University Medical Centre Ljubljana | Completed | Missed primary |
| Phase 1 | NCT03226431 | Dec 2017 → Jun 2019 | — | Duke University | Completed | No outcome recorded |
| Phase 1 | NCT03123107 | Jul 2017 → May 2019 | — | Geisinger Clinic | Completed | No outcome recorded |
| Phase 1 | NCT02762331 | Jan 2017 → Mar 2018 | atrial fibrillation, heart valve disorder, postoperative ventricular dysfunction, vitamin deficiency disorder | Virginia Commonwealth University | Terminated | No outcome recorded |
| Phase 1 | NCT02534753 | Sep → Nov 2015 | — | McGuff Pharmaceuticals, Inc. | Completed | No outcome recorded |
| Phase 1 | NCT02606773 | Jun → Sep 2015 | vitamin deficiency disorder | Semmelweis University | Completed | No outcome recorded |
| Phase 1 | NCT01654861 | Jun 2012 → Jun 2014 | pancreatic adenocarcinoma | Eastern Regional Medical Center | Terminated | No outcome recorded Stop: Enrollment |
| Phase 1 | NCT01833351 | May 2011 → Oct 2015 | — | University of Kansas Medical Center | Completed | No outcome recorded |
| Phase 1 | NCT01364805 | Apr 2011 → Oct 2015 | malignant pancreatic neoplasm | Jeanne Drisko, MD, CNS, FACN | Completed | No outcome recorded |
| Phase 1 | NCT01319734 | Feb 2011 → Dec 2015 | type 2 diabetes mellitus | Al-Neelain University | Unknown | No outcome recorded |
| Phase 1 | NCT01049880 | Dec 2009 → Feb 2013 | pancreatic neoplasm | Joseph J. Cullen | Completed | No outcome recorded |
| Phase 1 | NCT00954525 | Jul 2009 → Dec 2011 | malignant pancreatic neoplasm | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Completed | No outcome recorded |
| Phase 1 | NCT02966665 | Sep 2008 → Aug 2030 expected | chronic obstructive pulmonary disease, heart failure, pulmonary arterial hypertension | D. Walter Wray | Recruiting | No outcome recorded |
| Phase 1 | NCT00590603 | Jul 2008 → Dec 2012 | plasma cell myeloma | Duke University | Terminated | No outcome recorded Stop: Enrollment |
| Phase 1 | NCT00441207 | Aug 2006 → Jul 2010 | cancer | Midwestern Regional Medical Center | Completed | No outcome recorded |
| Phase 1 | NCT00117403 | Jan 2006 → Sep 2007 | Alzheimer disease | National Institute on Aging (NIA) | Completed | No outcome recorded |
| Phase 1 | NCT00258245 | May 2005 → Apr 2008 | plasma cell myeloma | Barbara Ann Karmanos Cancer Institute | Completed | No outcome recorded |
| Phase 1 | NCT00491751 | May 2004 → Jun 2012 | peripheral arterial disease | Boston University | Terminated | No outcome recorded Stop: Enrollment |
| Phase 1/218 trials | ||||||
| Phase 1/2 | NCT05157360 | Sep 2021 → May 2023 | infectious disease with sepsis, necrotizing soft tissue infection | Ascension Health | Terminated | No outcome recorded Stop: Enrollment |
| Phase 1/2 | NCT04035096 | Jan 2020 → Dec 2021 | colorectal cancer | National Taiwan University Hospital | Unknown | No outcome recorded |
| Phase 1/2 | NCT04046094 | Oct 2019 → Sep 2022 overdue | urinary bladder cancer | University of Kansas Medical Center | Active not recruiting | No outcome recorded |
| Phase 1/2 | NCT03697239 | Jun 2019 → Dec 2021 | pancreatic ductal adenocarcinoma | Hitendra Patel | Withdrawn | No outcome recorded |
| Phase 1/2 | NCT03908333 | May 2019 → May 2022 | pancreatic ductal adenocarcinoma | Medical College of Wisconsin | Withdrawn | No outcome recorded Stop: Business |
| Phase 1/2 | NCT03797443 | Jan 2019 → Jan 2022 | malignant pancreatic neoplasm | Piedmont Cancer Institute | Withdrawn | No outcome recorded |
| Phase 1/2 | NCT03799094 | Dec 2018 → Dec 2020 | non-small cell lung carcinoma | Clifford Hospital, Guangzhou, China | Unknown | No outcome recorded |
| Phase 1/2 | NCT03175341 | Oct 2018 → Oct 2019 | breast cancer | Academic Emergency County Hospital Sibiu | Unknown | No outcome recorded |
| Phase 1/2 | NCT03649633 | Sep 2018 → Jan 2023 | infectious disease with sepsis | University of Athens | Terminated | No outcome recorded Stop: Enrollment |
| Phase 1/2 | NCT03433781 | May 2018 → Nov 2022 | myelodysplastic syndrome | NYU Langone Health | Completed | No outcome recorded |
| Phase 1/2 | NCT03224572 | Jan → Dec 2018 | scurvy | National Taiwan University Hospital | Unknown | No outcome recorded |
| Phase 1/2 | NCT03410030 | Dec 2017 → Sep 2021 | pancreatic ductal adenocarcinoma | HonorHealth Research Institute | Completed | No outcome recorded |
| Phase 1/2 | NCT02655913 | Dec 2015 → Aug 2017 | non-small cell lung carcinoma | Clifford Hospital, Guangzhou, China | Completed | No outcome recorded |
| Phase 1/2 | NCT02602483 | Dec 2015 → Dec 2016 | temporomandibular joint disorder | Spherium Biomed | Completed | No outcome recorded |
| Phase 1/2 | NCT01754987 | Sep 2012 → Jan 2016 | hepatocellular carcinoma | Thomas Jefferson University | Completed | No outcome recorded |
| Phase 1/2 | NCT01550510 | Dec 2011 → Feb 2015 | colorectal cancer | Thomas Jefferson University | Terminated | No outcome recorded Stop: Enrollment |
| Phase 1/2 | NCT00661544 | Mar 2004 → Jun 2007 | plasma cell myeloma | M.D. Anderson Cancer Center | Completed | No outcome recorded |
| Phase 1/2 | NCT00006021 | Jun 2000 → May 2006 | plasma cell myeloma | University of Miami | Completed | No outcome recorded |
| Phase 272 trials · 4 met primary · 8 missed | ||||||
| Phase 2 | NCT07866274 | Nov 2026 → Nov 2027 expected | chronic rhinosinusitis | Assiut University | Not yet recruiting | No outcome recorded |
| Phase 2 | NCT07694375 | Jul 2026 → Jan 2027 expected | corneal disorder | Caravel Oculus Pty Ltd | Not yet recruiting | No outcome recorded |
| Phase 2 | NCT07310407 | Jan 2026 → Jan 2027 expected | metabolic dysfunction-associated steatotic liver disease | Ain Shams University | Not yet recruiting | No outcome recorded |
| Phase 2 | NCT06967428 | Sep 2025 → Jan 2026 overdue | — | Independent Medical Alliance | Not yet recruiting | No outcome recorded |
| Phase 2 | NCT07595705 | Aug 2025 → Jan 2027 expected | gingival disorder | Cairo University | Recruiting | No outcome recorded |
| Phase 2 | NCT06493370 | Jan 2025 → Dec 2028 expected | urinary bladder cancer | University of Kansas Medical Center | Recruiting | No outcome recorded |
| Phase 2 | NCT05849129 | Oct 2024 → Oct 2030 expected | lung cancer | The Canadian College of Naturopathic Medicine | Recruiting | No outcome recorded |
| Phase 2 | NCT06421688 | Jun 2024 → Jan 2025 | acute lung injury | Qianfoshan Hospital | Unknown | No outcome recorded |
| Phase 2 | NCT06123715 | Apr 2024 → Dec 2026 expected | chronic pain syndrome, osteoarthritis, knee | University Health Network, Toronto | Recruiting | No outcome recorded |
| Phase 2 | NCT05842382 | Jan 2024 → Dec 2025 | pneumonia | Clinical Research Centre, Malaysia | Unknown | No outcome recorded |
| Phase 2 | NCT05817851 | Dec 2023 → Dec 2027 expected | cardiac arrest | Centre Hospitalier de Bethune | Recruiting | No outcome recorded |
| Phase 2 | NCT05733078 | Nov 2023 → Mar 2024 | hypothyroidism, vitamin deficiency disorder | Dr Adnan Agha | Unknown | Met primary |
| Phase 2 | NCT04505878 | Apr → Dec 2023 | disease related to transplantation | University of Wisconsin, Madison | Withdrawn | No outcome recorded |
| Phase 2 | NCT05495243 | Oct 2022 → Feb 2024 | bronchiectasis | Renovion, Inc. | Completed | No outcome recorded |
| Phase 2 | NCT04898023 | Sep 2022 → Oct 2023 | viral respiratory tract infection | University of Missouri-Columbia | Terminated | No outcome recorded Stop: Business |
| Phase 2 | NCT06013540 | Aug → Dec 2022 | hyperpigmentation of the skin | Jinnah Postgraduate Medical Centre | Unknown | No outcome recorded |
| Phase 2 | NCT05194189 | Feb 2022 → Dec 2024 | infectious disease with sepsis | Zhujiang Hospital | Completed | No outcome recorded |
| Phase 2 | NCT04999137 | Sep → Dec 2021 | HIV infectious disease, infectious disease with sepsis | Liverpool School of Tropical Medicine | Unknown | No outcome recorded |
| Phase 2 | NCT04553666 | Apr 2021 → Aug 2023 | — | University of Rochester | Completed | No outcome recorded |
| Phase 2 | NCT04801511 | Mar 2021 → Jun 2023 | rectal cancer | Zhou Fuxiang | Unknown | No outcome recorded |
| Phase 2 | NCT05754242 | Nov 2020 → Jun 2023 | — | Hospital Universitario Ramon y Cajal | Unknown | No outcome recorded |
| Phase 2 | NCT04563000 | Oct 2020 → Oct 2022 | brain injury, cardiac arrest | University Medical Centre Maribor | Unknown | No outcome recorded |
| Phase 2 | NCT05561257 | Jul 2020 → Feb 2024 | neuropathy, painful | Pascoe Pharmazeutische Praeparate GmbH | Terminated | No outcome recorded Stop: Enrollment |
| Phase 2 | NCT04033107 | Jul 2020 → Dec 2024 | colorectal cancer, gastric cancer, hepatocellular carcinoma, malignant pancreatic neoplasm | Zhongnan Hospital | Unknown | No outcome recorded |
| Phase 2 | NCT04363216 | May 2020 → May 2021 | COVID-19 | Thomas Jefferson University | Unknown | No outcome recorded |
| Phase 2 | NCT04264533 | Feb → Mar 2020 | viral pneumonia | ZhiYong Peng | Terminated | No outcome recorded |
| Phase 2 | NCT01125449 | Jan → Jun 2020 | adenocarcinoma, desmoplastic small round cell tumor, plasma cell myeloma | Situs Cancer Research Center | Withdrawn | No outcome recorded |
| Phase 2 | NCT03964688 | Dec 2019 → Mar 2022 | plasma cell myeloma | Maastricht University Medical Center | Completed | No outcome recorded |
| Phase 2 | NCT04153487 | Nov 2019 → Jul 2021 | acute lung injury | Damanhour University | Completed | No outcome recorded |
| Phase 2 | NCT03707483 | Feb → Nov 2019 | periodontal disorder | Cairo University | Unknown | No outcome recorded |
| Phase 2 | NCT03756220 | Dec 2018 → Jan 2020 | infectious disease with sepsis | Tae Gun Shin | Completed | No outcome recorded |
| Phase 2 | NCT02905591 | Nov 2018 → Jul 2025 overdue | non-small cell lung carcinoma | Joseph J. Cullen, MD, FACS | Active not recruiting | No outcome recorded |
| Phase 2 | NCT03613727 | Oct 2018 → Oct 2022 | lymphoid leukemia, monocytic leukemia, myelodysplastic syndrome, myeloid leukemia | Virginia Commonwealth University | Completed | No outcome recorded |
| Phase 2 | NCT03592277 | Sep 2018 → Feb 2021 | infectious disease with sepsis | Trinity Health Of New England | Completed | Missed primary |
| Phase 2 | NCT03592693 | Sep 2018 → Jan 2023 | — | University of Athens | Terminated | No outcome recorded Stop: Enrollment |
| Phase 2 | NCT03418038 | Mar 2018 → Feb 2031 expected | Hodgkins lymphoma, chronic myelomonocytic leukemia, clonal hematopoiesis, diffuse large B-cell lymphoma +1 | Mayo Clinic | Recruiting | No outcome recorded |
| Phase 2 | NCT03397173 | Mar 2018 → Jan 2021 | acute myeloid leukemia, myelodysplastic syndrome | Case Comprehensive Cancer Center | Completed | No outcome recorded |
| Phase 2 | NCT03334409 | Feb 2018 → Mar 2021 | clear cell renal carcinoma | Academic and Community Cancer Research United | Terminated | Missed primary Stop: Business |
| Phase 2 | NCT03422159 | Feb 2018 → Jun 2019 | infectious disease with sepsis | Community Medical Center, Toms River, NJ | Completed | Met primary |
| Phase 2 | NCT01587261 | Jun 2017 | — | University of Texas Southwestern Medical Center | Withdrawn | No outcome recorded |
| Phase 2 | NCT02521077 | May 2017 → Mar 2019 | — | Midwestern Regional Medical Center | Withdrawn | No outcome recorded |
| Phase 2 | NCT03146962 | Mar 2017 → Apr 2023 | colorectal cancer, lung cancer, malignant pancreatic neoplasm | Weill Medical College of Cornell University | Completed | No outcome recorded |
| Phase 2 | NCT02344355 | Mar 2017 → Dec 2027 expected | glioblastoma | Bryan Allen | Active not recruiting | No outcome recorded |
| Phase 2 | NCT02979223 | Nov 2016 → Jun 2017 | — | National Cancer Center, Korea | Completed | No outcome recorded |
| Phase 2 | NCT02516670 | Jun 2016 → Jul 2021 | hormone-resistant prostate carcinoma, metastatic prostate carcinoma | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Terminated | Missed primary |
| Phase 2 | NCT02421887 | Dec 2015 → Jun 2018 | male infertility | Yale University | Completed | Missed primary |
| Phase 2 | NCT02420314 | Apr 2015 → Dec 2021 | non-small cell lung carcinoma | Joseph J. Cullen, MD, FACS | Completed | Met primary |
| Phase 2 | NCT02186158 | Feb 2015 → May 2016 | pneumonia | University Hospital, Bordeaux | Terminated | No outcome recorded |
| Phase 2 | NCT02793648 | Oct 2014 → Nov 2017 | depressive disorder | Yolanda de Diego Otero | Completed | No outcome recorded |
| Phase 2 | NCT01897792 | May 2013 → Feb 2015 | bacterial pneumonia, blood coagulation disease | University of Alabama at Birmingham | Terminated | No outcome recorded Stop: Enrollment |
| Phase 2 | NCT01515046 | Sep 2012 → Jul 2015 | malignant pancreatic neoplasm | Joseph J. Cullen | Terminated | No outcome recorded Stop: Enrollment |
| Phase 2 | NCT01590303 | May 2012 → Jun 2013 | infectious disease with sepsis | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Unknown | No outcome recorded |
| Phase 2 | NCT01555489 | Oct 2011 → Jan 2016 | pancreas disorder | Thomas Jefferson University | Terminated | No outcome recorded Stop: Enrollment |
| Phase 2 | NCT02062034 | Feb 2011 → Nov 2013 | diabetic retinopathy, type 2 diabetes mellitus | University of Guadalajara | Completed | No outcome recorded |
| Phase 2 | NCT01080352 | Nov 2010 → Sep 2014 | prostate cancer | Copenhagen University Hospital at Herlev | Completed | Missed primary |
| Phase 2 | NCT00808470 | Oct 2008 → Dec 2013 | noise induced hearing loss | University of Michigan | Completed | Missed primary |
| Phase 2 | NCT01270152 | Oct 2008 → Dec 2009 | — | University of Sao Paulo | Completed | No outcome recorded |
| Phase 2 | NCT00626444 | Feb 2008 → Dec 2011 | non-Hodgkin lymphoma | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Terminated | No outcome recorded Stop: Enrollment |
| Phase 2 | NCT00621023 | Nov 2007 → Apr 2010 | myelodysplastic syndrome | Duke University | Completed | No outcome recorded |
| Phase 2 | NCT00532844 | Sep 2007 → Nov 2008 | — | BioMarin Pharmaceutical | Completed | Met primary |
| Phase 2 | NCT00388856 | Oct 2006 → Nov 2009 | preeclampsia | Showa University | Completed | No outcome recorded |
| Phase 2 | NCT00271635 | Jan 2006 → Jul 2007 | Charcot-Marie-Tooth disease, hereditary motor and sensory neuropathy | Academic Medical Center - University of Amsterdam | Completed | Missed primary |
| Phase 2 | NCT00317811 | Nov 2005 → Feb 2009 | plasma cell myeloma | Oncotherapeutics | Completed | No outcome recorded |
| Phase 2 | NCT00803530 | Sep 2005 → Jan 2007 | myelodysplastic syndrome | Fondazione Italiana Sindromi Mielodisplastiche-ETS | Terminated | No outcome recorded Stop: Enrollment |
| Phase 2 | NCT00284427 | Sep 2005 → Dec 2006 | cervical cancer, ovarian cancer, uterine corpus cancer | Jeanne Drisko, MD, CNS, FACN | Completed | No outcome recorded |
| Phase 2 | NCT00963131 | Dec 2004 → Dec 2008 | central serous chorioretinopathy | Prince of Songkla University | Completed | No outcome recorded |
| Phase 2 | NCT00184054 | Apr 2002 → Jun 2009 | acute myeloid leukemia | University of Southern California | Terminated | No outcome recorded |
| Phase 2 | NCT00067899 | Sep 2000 → Dec 2005 | — | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Completed | No outcome recorded |
| Phase 2 | NCT00000600 | Jun 1995 → May 2000 | atherosclerosis, carotid artery disorder, heart disorder, intracranial arteriosclerosis | National Heart, Lung, and Blood Institute (NHLBI) | Terminated | No outcome recorded |
| Phase 2 | NCT00000541 | May 1993 → Jul 2005 | coronary atherosclerosis, myocardial infarction, myocardial ischemia | Brigham and Women's Hospital | Completed | Missed primary |
| Phase 2 | NCT00112879 | — | plasma cell myeloma | The Cleveland Clinic | Withdrawn | No outcome recorded |
| Phase 2 | NCT00085345 | — | plasma cell myeloma, refractory plasma cell neoplasm | Oncotherapeutics | Withdrawn | No outcome recorded |
| Phase 2/313 trials · 3 missed | ||||||
| Phase 2/3 | NCT06601283 | Nov 2024 → Nov 2026 expected | malignant pancreatic neoplasm | Fudan University | Recruiting | No outcome recorded |
| Phase 2/3 | NCT06598033 | Nov 2024 → Oct 2026 expected | malignant pancreatic neoplasm | Fudan University | Recruiting | No outcome recorded |
| Phase 2/3 | NCT06146296 | Nov 2023 → Jun 2024 | — | Nourhan M.Aly | Unknown | No outcome recorded |
| Phase 2/3 | NCT05281562 | Feb → Mar 2023 | diabetes mellitus, diabetic neuropathy, ulcer of lower limbs | Prisma Health-Midlands | Terminated | No outcome recorded Stop: Enrollment |
| Phase 2/3 | NCT05694975 | Jan → Apr 2023 | pneumonia | Zhujiang Hospital | Unknown | No outcome recorded |
| Phase 2/3 | NCT05283954 | May → Jun 2022 | COVID-19 | Oriol Mitja | Withdrawn | No outcome recorded Stop: Business |
| Phase 2/3 | NCT03380507 | Mar 2018 → Oct 2019 | infectious disease with sepsis | Hamad Medical Corporation | Terminated | Missed primary Stop: Business |
| Phase 2/3 | NCT03389555 | Feb 2018 → Nov 2019 | infectious disease with sepsis, metabolic disease | Beth Israel Deaconess Medical Center | Completed | Missed primary |
| Phase 2/3 | NCT02868151 | Aug 2016 → Dec 2017 | mucositis | Panineeya Mahavidyalaya Institute of Dental Sciences & Research Centre | Completed | No outcome recorded |
| Phase 2/3 | NCT02745873 | May → Jul 2012 | lead poisoning | Aga Khan University | Completed | No outcome recorded |
| Phase 2/3 | NCT01125033 | Mar 2008 → Jan 2009 | chronic kidney disease, restless legs syndrome | Shiraz University of Medical Sciences | Completed | No outcome recorded |
| Phase 2/3 | NCT00484510 | Apr 2007 → Dec 2012 | Charcot-Marie-Tooth disease | Wayne State University | Completed | Missed primary |
| Phase 2/3 | NCT00419146 | Sep 2001 → Apr 2004 | schizoaffective disorder, schizophrenia, schizophreniform disorder | University Hospital, Aker | Completed | No outcome recorded |
| Phase 347 trials · 1 met primary · 11 missed | ||||||
| Phase 3 | NCT04516681 | Dec 2024 → Dec 2025 overdue | colorectal cancer | Fudan University | Recruiting | No outcome recorded |
| Phase 3 | NCT05654922 | Apr 2023 → May 2026 overdue | bronchiolitis obliterans syndrome | Renovion, Inc. | Recruiting | No outcome recorded |
| Phase 3 | NCT05726097 | Feb → Oct 2023 | colorectal cancer, inflammatory bowel disease, polyp of colon | Region Skane | Completed | No outcome recorded |
| Phase 3 | NCT05614349 | Jan 2023 → Apr 2025 overdue | COVID-19 | Unity Health Toronto | Active not recruiting | Missed primary |
| Phase 3 | NCT05350124 | Nov 2022 → Dec 2023 | end stage renal failure, restless legs syndrome | King Abdulaziz University | Unknown | No outcome recorded |
| Phase 3 | NCT04088591 | Oct 2022 → Nov 2023 | infectious disease with sepsis | Virginia Commonwealth University | Withdrawn | No outcome recorded |
| Phase 3 | NCT05327348 | Sep 2022 → Jul 2023 | ischemic disease | University of Malaya | Unknown | No outcome recorded |
| Phase 3 | NCT04404387 | Jul 2022 → Jul 2024 | acute respiratory distress syndrome | Assistance Publique - Hôpitaux de Paris | Unknown | No outcome recorded |
| Phase 3 | NCT05029037 | Sep 2021 → Mar 2022 | COVID-19 | Hugo Galindo | Unknown | No outcome recorded |
| Phase 3 | NCT05192213 | Aug 2021 → Jul 2022 | infectious disease with sepsis | Hospital Sirio-Libanes | Terminated | No outcome recorded Stop: Enrollment |
| Phase 3 | NCT04401150 | Aug 2020 → Jul 2022 | COVID-19 | University of Sherbrooke | Completed | Missed primary |
| Phase 3 | NCT04138394 | Jul 2020 → Dec 2025 | — | Clinical Evaluation Research Unit at Kingston General Hospital | Suspended | Missed primary Stop: Enrollment |
| Phase 3 | NCT04446104 | May → Aug 2020 | COVID-19 | National University Hospital, Singapore | Completed | No outcome recorded |
| Phase 3 | NCT04134403 | Dec 2019 → Nov 2020 | infectious disease with sepsis | Baqiyatallah Medical Sciences University | Unknown | No outcome recorded |
| Phase 3 | NCT03828929 | Oct 2019 → Jan 2020 | infectious disease with sepsis | New York Presbyterian Brooklyn Methodist Hospital | Terminated | No outcome recorded |
| Phase 3 | NCT03965637 | Aug 2019 → Jan 2020 | — | Shahid Beheshti University | Completed | No outcome recorded |
| Phase 3 | NCT04508946 | Aug 2019 → Nov 2020 | infectious disease with sepsis | Air Force Specialized Hospital, Cairo, Egypt | Completed | No outcome recorded |
| Phase 3 | NCT03835286 | Mar 2019 → Dec 2022 | infectious disease with sepsis | Hospital Español de Mexico | Withdrawn | No outcome recorded |
| Phase 3 | NCT03872011 | Feb 2019 → Sep 2021 | infectious disease with sepsis | Northern Jiangsu People's Hospital | Completed | Missed primary |
| Phase 3 | NCT03725384 | Jan 2019 → Jan 2022 | iron deficiency anemia | Sunnybrook Health Sciences Centre | Completed | No outcome recorded |
| Phase 3 | NCT03680274 | Nov 2018 → Aug 2021 | COVID-19, infectious disease with sepsis | University of Sherbrooke | Completed | Missed primary |
| Phase 3 | NCT03702374 | Sep 2018 → Nov 2020 | diabetic retinopathy | University of Guadalajara | Completed | No outcome recorded |
| Phase 3 | NCT03509350 | Aug 2018 → Aug 2019 | infectious disease with sepsis | Emory University | Completed | Missed primary |
| Phase 3 | NCT03557229 | Jul 2018 → Jun 2022 | disorder of defective peroxisome oxidative status, infectious disease with sepsis | American British Cowdray Medical Center | Unknown | No outcome recorded |
| Phase 3 | NCT03015675 | Mar → Dec 2017 | gastric cancer | Sun Yat-sen University | Unknown | No outcome recorded |
| Phase 3 | NCT02730364 | Feb → Apr 2017 | respiratory tract infectious disorder | GlaxoSmithKline | Withdrawn | No outcome recorded |
| Phase 3 | NCT02678234 | Feb → Apr 2017 | respiratory tract infectious disorder | GlaxoSmithKline | Withdrawn | No outcome recorded |
| Phase 3 | NCT02969681 | Jan 2017 → Dec 2020 | colorectal neoplasm | Sun Yat-sen University | Completed | No outcome recorded |
| Phase 3 | NCT02390505 | Jul 2016 → Jul 2025 | complex regional pain syndrome type 1 | Centre Hospitalier Universitaire, Amiens | Completed | No outcome recorded |
| Phase 3 | NCT02942498 | Jul 2016 → Sep 2017 | fragile X syndrome | Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud | Completed | No outcome recorded |
| Phase 3 | NCT02735707 | Apr 2016 → Feb 2026 overdue | pneumonia | UMC Utrecht | Recruiting | Mixed |
| Phase 3 | NCT02629536 | Mar 2016 → Mar 2017 | migraine disorder | University of Notre Dame Australia | Unknown | No outcome recorded |
| Phase 3 | NCT02540031 | Sep 2015 → Apr 2018 | — | Kyungpook National University Hospital | Completed | No outcome recorded |
| Phase 3 | NCT01715597 | Dec 2012 → Oct 2017 | uterine corpus leiomyoma | Seoul National University Hospital | Completed | Missed primary |
| Phase 3 | NCT01580683 | Jul 2012 → Jul 2015 | atrial fibrillation | Regional Hospital of Scranton | Withdrawn | No outcome recorded Stop: Enrollment |
| Phase 3 | NCT01501968 | Jan 2012 → Dec 2013 | — | Mahidol University | Unknown | Missed primary |
| Phase 3 | NCT00231218 | Jan → Mar 2006 | common cold, gastroenteritis | The Cleveland Clinic | Completed | No outcome recorded |
| Phase 3 | NCT00387114 | Jun → Nov 2005 | disorder of defective peroxisome oxidative status | University of Turin, Italy | Terminated | No outcome recorded |
| Phase 3 | NCT00116493 | Apr 2004 → May 2007 | anemia | Johns Hopkins Bloomberg School of Public Health | Completed | Missed primary |
| Phase 3 | NCT00097110 | Jul 2003 → Dec 2006 | HELLP syndrome, eclampsia | NICHD Global Network for Women's and Children's Health | Completed | Missed primary |
| Phase 3 | NCT00135707 | Jun 2003 → Oct 2008 | preeclampsia | The George Washington University Biostatistics Center | Completed | Missed primary |
| Phase 3 | NCT00515736 | Jan 2003 → Dec 2005 | subarachnoid hemorrhage | Centre Hospitalier Universitaire Vaudois | Terminated | No outcome recorded Stop: Enrollment |
| Phase 3 | NCT00000555 | Aug 1996 → May 2003 | coronary atherosclerosis, myocardial ischemia | National Heart, Lung, and Blood Institute (NHLBI) | Completed | No outcome recorded |
| Phase 3 | NCT00339768 | Jul 1995 → Jun 1996 | preneoplastic lesion | National Cancer Institute (NCI) | Completed | Mixed |
| Phase 3 | NCT00000161 | Aug 1993 → ? | age-related macular degeneration, cataract | National Eye Institute (NEI) | Unknown | Met primary |
| Phase 3 | NCT00000539 | Sep 1992 → Mar 1999 | arterial occlusion, diabetes mellitus, heart disorder | National Heart, Lung, and Blood Institute (NHLBI) | Completed | No outcome recorded |
| Phase 3 | NCT01437826 | Mar 1988 → Jun 1996 | colorectal adenoma | IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy | Terminated | No outcome recorded |
| Phase 437 trials · 4 met primary · 4 missed | ||||||
| Phase 4 | NCT04756063 | Sep 2026 → Mar 2031 | liver failure | University of Wisconsin, Madison | Withdrawn | No outcome recorded |
| Phase 4 | NCT07376148 | Nov 2025 → Feb 2026 overdue | skin disorder | Instituto de Oftalmología Fundación Conde de Valenciana | Recruiting | No outcome recorded |
| Phase 4 | NCT07414693 | Aug 2025 → Feb 2026 overdue | pneumonia | Children's Hospital and Institute of Child Health, Multan | Recruiting | No outcome recorded |
| Phase 4 | NCT06823999 | Aug 2025 → Jul 2028 expected | ischemic stroke, skin disorder | Chiayi Christian Hospital | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT06384833 | May 2024 → Sep 2025 | rotator cuff syndrome | Mahidol University | Unknown | Missed primary |
| Phase 4 | NCT06354582 | Apr → Oct 2024 | obstetric disorder | Kunyue Li | Unknown | No outcome recorded |
| Phase 4 | NCT05842395 | Jun 2023 → May 2024 | — | Damascus University | Completed | No outcome recorded |
| Phase 4 | NCT05054036 | Jan 2022 → Jul 2024 | — | Yale University | Completed | Met primary |
| Phase 4 | NCT04472000 | Apr 2021 → May 2023 | frozen shoulder | Lindenhofgruppe AG | Terminated | No outcome recorded Stop: Enrollment |
| Phase 4 | NCT06074367 | Oct 2020 → Oct 2023 | atrial fibrillation | Helwan University | Unknown | No outcome recorded |
| Phase 4 | NCT04468139 | Jun → Jul 2020 | COVID-19 | Ministry of Health, Saudi Arabia | Unknown | No outcome recorded |
| Phase 4 | NCT04334967 | Mar 2020 → May 2021 | COVID-19 | Providence Health & Services | Suspended | No outcome recorded |
| Phase 4 | NCT04210453 | Mar 2020 → Dec 2022 | acute kidney injury | Yonsei University | Unknown | No outcome recorded |
| Phase 4 | NCT02225886 | Feb 2020 → Mar 2023 | anemia | Anemia Working Group Romania | Unknown | No outcome recorded |
| Phase 4 | NCT04039815 | Dec 2019 → Dec 2020 | infectious disease with sepsis | Far Eastern Memorial Hospital | Unknown | No outcome recorded |
| Phase 4 | NCT03921099 | Jan 2019 → Jul 2020 | acute kidney injury | Ain Shams University | Unknown | Mixed |
| Phase 4 | NCT06152458 | Jan 2019 → Mar 2020 | infectious disease with sepsis | University of Pecs | Completed | No outcome recorded |
| Phase 4 | NCT04135378 | Nov 2018 → Mar 2019 | — | Kufa University | Completed | No outcome recorded |
| Phase 4 | NCT03639519 | Apr 2018 → Apr 2019 | — | El-Galaa Military Medical Complex | Unknown | No outcome recorded |
| Phase 4 | NCT03494387 | Apr 2018 → Mar 2020 | — | University Hospital Bispebjerg and Frederiksberg | Completed | Missed primary |
| Phase 4 | NCT03335124 | Sep 2017 → Dec 2018 | infectious disease with sepsis | University Medical Centre Ljubljana | Terminated | No outcome recorded Stop: Enrollment |
| Phase 4 | NCT02992028 | Dec 2016 → May 2017 | rotator cuff syndrome | Himchan Hospital | Unknown | No outcome recorded |
| Phase 4 | NCT02631668 | Jan 2016 → Dec 2018 | iron deficiency anemia | Huashan Hospital | Completed | Met primary |
| Phase 4 | NCT03252418 | Oct 2015 → Sep 2016 | hyperpigmentation of the skin | Ain Shams University | Completed | No outcome recorded |
| Phase 4 | NCT02455180 | Mar 2015 → Oct 2016 | infectious disease with sepsis, multiple organ dysfunction syndrome | Amsterdam UMC, location VUmc | Completed | No outcome recorded |
| Phase 4 | NCT02290093 | Nov 2014 → Sep 2015 | — | Kyunghee University Medical Center | Completed | Met primary |
| Phase 4 | NCT03228238 | Sep 2014 → Jun 2024 | Prinzmetal angina | Seoul National University Hospital | Terminated | No outcome recorded Stop: Enrollment |
| Phase 4 | NCT02073552 | May 2014 → Dec 2015 | — | Fundación Canaria Rafael Clavijo para la Investigación Biomédica | Completed | Missed primary |
| Phase 4 | NCT01926132 | Aug → Oct 2013 | myalgic encephalomeyelitis/chronic fatigue syndrome | Yonsei University | Unknown | No outcome recorded |
| Phase 4 | NCT01743742 | May → Sep 2013 | perinatal asphyxia | Sir Takhtasinhji General Hospital | Completed | Missed primary |
| Phase 4 | NCT01865916 | Apr 2013 → Dec 2015 | — | University of British Columbia | Completed | No outcome recorded |
| Phase 4 | NCT01413360 | Aug 2011 → Dec 2013 | alcoholic hepatitis, chronic hepatitis C virus infection | Seoul National University Hospital | Completed | No outcome recorded |
| Phase 4 | NCT01356433 | Aug 2011 → Jun 2012 | uremia | Peking University First Hospital | Completed | No outcome recorded |
| Phase 4 | NCT01127282 | Dec 2009 → Jun 2010 | swine influenza | Seoul National University Hospital | Unknown | No outcome recorded |
| Phase 4 | NCT00303160 | Mar 2006 → Sep 2007 | Helicobacter pylori infectious disease | University of Toronto | Unknown | No outcome recorded |
| Phase 4 | NCT00356954 | Feb 2005 → Apr 2006 | kidney failure | Seoul National University Hospital | Completed | No outcome recorded |
| Phase 4 | NCT00296868 | Jan 2001 → Dec 2005 | complex regional pain syndrome type 1 | Stichting Achmea Slachtoffer en Samenleving | Completed | Met primary |
| Phase not applicable48 trials · 2 missed | ||||||
| — | NCT07848035 | Oct 2026 → Jul 2027 expected | — | University of Science and Technology, Yemen | Not yet recruiting | No outcome recorded |
| — | NCT07184866 | Apr 2026 → Jul 2027 expected | liver disorder | Institute of Liver and Biliary Sciences, India | Not yet recruiting | No outcome recorded |
| — | NCT06968936 | Mar 2026 → Jun 2029 expected | iron deficiency anemia | Second Affiliated Hospital, School of Medicine, Zhejiang University | Recruiting | No outcome recorded |
| — | NCT07369232 | Sep 2025 → Mar 2026 | disorder of defective peroxisome oxidative status, polycythemia due to hypoxia | Erasme University Hospital | Completed | No outcome recorded |
| — | NCT06857734 | Mar 2025 → May 2026 overdue | — | Benha University | Not yet recruiting | No outcome recorded |
| — | NCT06897384 | Mar 2025 → Jan 2026 overdue | acute pancreatitis | Ruijin Hospital | Active not recruiting | No outcome recorded |
| — | NCT06788132 | Jan → Jul 2025 | preterm premature rupture of the membranes | Ricardo A Gutierrez Ramirez, MD, MSc, FACOG | Completed | No outcome recorded |
| — | NCT06012760 | Jan 2025 → Jan 2028 expected | iron deficiency anemia | Second Affiliated Hospital, School of Medicine, Zhejiang University | Recruiting | No outcome recorded |
| — | NCT06781970 | Dec 2024 → Mar 2025 overdue | cataract, corneal disorder | Indonesia University | Recruiting | No outcome recorded |
| — | NCT06723626 | Jul 2024 → Aug 2026 | vascular disorder | Southeast University, China | Completed | No outcome recorded |
| — | NCT06345092 | Apr → May 2024 | temporomandibular joint dysfunction syndrome | Cairo University | Completed | No outcome recorded |
| — | NCT07557173 | Jan 2024 → Jun 2026 overdue | — | Ospedale San Pio | Recruiting | No outcome recorded |
| — | NCT05975125 | Jun 2023 → Jun 2024 | anemia | Department of Medical Services Ministry of Public Health of Thailand | Completed | No outcome recorded |
| — | NCT05770596 | Apr 2023 → Dec 2024 | myofascial pain syndrome, scurvy | Tanta University | Completed | No outcome recorded |
| — | NCT05353348 | Mar 2023 → Apr 2025 overdue | iron deficiency anemia | Second Affiliated Hospital, School of Medicine, Zhejiang University | Recruiting | No outcome recorded |
| — | NCT06780345 | Feb → Aug 2023 | neonatal sepsis | Tanta University | Completed | No outcome recorded |
| — | NCT07060859 | Jan → Jun 2023 | — | Manar Ziad Foura-Matar | Completed | No outcome recorded |
| — | NCT05514197 | Nov 2022 → Dec 2023 | — | Chimei Medical Center | Completed | No outcome recorded |
| — | NCT05423249 | Aug 2022 → Nov 2024 | disorder of iron metabolism and transport | Stony Brook University | Completed | No outcome recorded |
| — | NCT05478044 | Aug 2022 → Aug 2023 | — | Cairo University | Unknown | No outcome recorded |
| — | NCT04494451 | Sep 2021 → Nov 2022 | cirrhosis of liver | Institute of Liver and Biliary Sciences, India | Completed | No outcome recorded |
| — | NCT04935515 | Apr → May 2021 | COVID-19 | Manimarane Arjunan, MD,DM (Cardiology) | Completed | No outcome recorded |
| — | NCT06042738 | Mar → Nov 2021 | male infertility | Ondokuz Mayıs University | Completed | No outcome recorded |
| — | NCT04693936 | Feb 2021 → Sep 2024 | Hashimoto thyroiditis, psoriasis | University of Crete | Unknown | No outcome recorded |
| — | NCT04570254 | Aug → Dec 2020 | COVID-19, acute respiratory distress syndrome, viral pneumonia | Unidad Temporal COVID-19 en Centro Citibanamex | Completed | No outcome recorded |
| — | NCT04445727 | May 2020 → Jan 2021 | epicondylitis | Universidad Rey Juan Carlos | Unknown | No outcome recorded |
| — | NCT04664010 | Feb 2020 → Sep 2022 | COVID-19 | Xi'an International Medical Center Hospital | Completed | No outcome recorded |
| — | NCT04160676 | Dec 2019 → Jul 2021 | infectious disease with sepsis | Tanta University | Completed | No outcome recorded |
| — | NCT04697992 | Nov 2019 → Mar 2020 | hyperpigmentation of eyelid | Kasr El Aini Hospital | Completed | No outcome recorded |
| — | NCT07076108 | Aug 2019 → Apr 2024 | end stage renal failure | Ain Shams University | Completed | No outcome recorded |
| — | NCT04137276 | Apr → Jul 2019 | infectious disease with sepsis | Indonesia University | Completed | No outcome recorded |
| — | NCT03821714 | Feb 2019 → Jan 2020 | infectious disease with sepsis | Southeast University, China | Completed | No outcome recorded |
| — | NCT04773717 | Jan 2019 → Jan 2021 | infectious disease with sepsis | Lithuanian University of Health Sciences | Completed | No outcome recorded |
| — | NCT02838472 | Jun 2016 → Aug 2017 | adrenocortical insufficiency | Hadassah Medical Organization | Unknown | No outcome recorded |
| — | NCT02553551 | Jul 2015 → Sep 2017 | cholecystitis, cholelithiasis | Taeho Hong | Unknown | No outcome recorded |
| — | NCT02216812 | Aug 2014 → Dec 2017 | — | Massachusetts General Hospital | Completed | Missed primary |
| — | NCT01929668 | Aug 2013 → Dec 2014 | ulcerative colitis | Kyungpook National University Hospital | Completed | No outcome recorded |
| — | NCT02127060 | Feb 2013 → May 2014 | vertebral joint disorder | Seoul National University Hospital | Completed | No outcome recorded |
| — | NCT01188005 | Aug → Oct 2010 | obstructive sleep apnea syndrome | University of Athens | Unknown | No outcome recorded |
| — | NCT00995670 | Mar 2010 → Sep 2013 | hyperglycemia | US Department of Veterans Affairs | Completed | No outcome recorded |
| — | NCT00786019 | May 2008 → Oct 2011 | type 2 diabetes mellitus | University of Colorado, Denver | Completed | No outcome recorded |
| — | NCT00550121 | Aug 2007 → Apr 2008 | heart failure | Radboud University Medical Center | Completed | No outcome recorded |
| — | NCT00534924 | Aug 2007 → ? | ischemic disease | Medical University of Vienna | Unknown | No outcome recorded |
| — | NCT00350077 | Jul 2006 → Mar 2008 | — | United States Army Institute of Surgical Research | Withdrawn | No outcome recorded |
| — | NCT00172302 | Nov 2005 → ? | chronic renal failure syndrome | National Taiwan University Hospital | Unknown | No outcome recorded |
| — | NCT00001070 | — | HIV infectious disease | National Institute of Allergy and Infectious Diseases (NIAID) | Withdrawn | No outcome recorded |
| — | NCT00378456 | — | trisomy 21 | Institute of Child Health | Completed | Missed primary |
| — | NCT00037063 | — | HIV infectious disease | National Institute of Allergy and Infectious Diseases (NIAID) | Withdrawn | No outcome recorded |
| Phase not stated1 trial | ||||||
| — | NCT01198860 | — | chronic hepatitis B virus infection | Nguyen Thi Trieu, MD | Approved for marketing | No outcome recorded |
| Comparator or background therapy94 trials | ||||||
| Phase 0 | NCT07121127 Background | Jul 2026 → Aug 2029 expected | age-related macular degeneration | Zhiming Yan | Not yet recruiting | No outcome recorded |
| Phase 0 | NCT01210430 Comparator | Jul 2010 → Jun 2015 | postural orthostatic tachycardia syndrome | New York Medical College | Completed | No outcome recorded |
| Phase 1 | NCT03166787 Background | Aug 2017 → Apr 2020 | — | Cedars-Sinai Medical Center | Terminated | No outcome recorded |
| Phase 1 | NCT00325572 Comparator | Nov 2006 → Dec 2010 | autism spectrum disorder | Milton S. Hershey Medical Center | Terminated | No outcome recorded |
| Phase 1/2 | NCT07070024 Comparator | Jul 2025 → Jul 2026 overdue | gingival disorder | Fayoum University | Not yet recruiting | No outcome recorded |
| Phase 1/2 | NCT04715022 Comparator | Jun 2021 → Aug 2026 overdue | hypertensive disorder | University of Kansas Medical Center | Recruiting | No outcome recorded |
| Phase 1/2 | NCT04708340 Comparator | Mar 2021 → Oct 2022 | COVID-19, acute respiratory distress syndrome | Reven Pharmaceuticals, Inc. | Unknown | No outcome recorded |
| Phase 1/2 | NCT04591600 Background | Jul → Sep 2020 | COVID-19 | Alkarkh Health Directorate-Baghdad | Completed | No outcome recorded |
| Phase 1/2 | NCT02206425 Background | Sep 2014 → Jan 2018 | plasma cell myeloma | Oncotherapeutics | Completed | No outcome recorded |
| Phase 1/2 | NCT01434121 Comparator | May 2010 → Sep 2012 | acute hypotension, acute lung injury, infectious disease with sepsis | Virginia Commonwealth University | Completed | No outcome recorded |
| Phase 1/2 | NCT00469209 Comparator | Jun 2006 → Dec 2008 | plasma cell myeloma | M.D. Anderson Cancer Center | Completed | No outcome recorded |
| Phase 2 | NCT05913180 Comparator | Sep 2023 → Aug 2026 overdue | urinary tract infection | American University of Beirut Medical Center | Recruiting | No outcome recorded |
| Phase 2 | NCT04921189 Comparator | Dec 2021 → Dec 2024 | cardiac arrest, post-cardiac arrest syndrome | Asan Medical Center | Completed | No outcome recorded |
| Phase 2 | NCT04291508 Comparator | Oct 2021 → Apr 2023 | acute respiratory distress syndrome, infectious disease with sepsis | Massachusetts General Hospital | Completed | No outcome recorded |
| Phase 2 | NCT04689815 Background | Jan 2021 → Dec 2023 | acute myeloid leukemia with mutated NPM1 | The University of Hong Kong | Unknown | No outcome recorded |
| Phase 2 | NCT04687176 Background | Jan 2021 → Dec 2025 overdue | acute promyelocytic leukemia | The University of Hong Kong | Recruiting | No outcome recorded |
| Phase 2 | NCT05398965 Background | Nov 2020 → Jan 2021 | COVID-19 | Hasanuddin University | Completed | No outcome recorded |
| Phase 2 | NCT04279197 Background | Apr 2020 → Mar 2021 | postinflammatory pulmonary fibrosis | ShuGuang Hospital | Completed | No outcome recorded |
| Phase 2 | NCT04071977 Comparator | Mar 2020 → Oct 2021 | diabetes mellitus, diabetic retinopathy | University of Guadalajara | Completed | No outcome recorded |
| Phase 2 | NCT03509662 Comparator | Oct 2019 → Feb 2024 | cardiac arrest | Amsterdam UMC, location VUmc | Completed | No outcome recorded |
| Phase 2 | NCT03968042 Background | Jun 2019 → Dec 2021 | brain injury | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Unknown | Mixed |
| Phase 2 | NCT03829683 Comparator | Apr 2019 → Mar 2022 | alcoholic hepatitis, infectious disease with sepsis | Virginia Commonwealth University | Completed | No outcome recorded |
| Phase 2 | NCT03624270 Background | Aug 2018 → Sep 2023 | acute promyelocytic leukemia | The University of Hong Kong | Unknown | No outcome recorded |
| Phase 2 | NCT03333278 Comparator | May 2018 → Jul 2019 | infectious disease with sepsis | Australian and New Zealand Intensive Care Research Centre | Completed | No outcome recorded |
| Phase 2 | NCT03148236 Comparator | Sep 2017 → Mar 2018 | atrial fibrillation | Virginia Commonwealth University | Completed | No outcome recorded |
| Phase 2 | NCT03269799 Comparator | Aug 2017 → Feb 2018 | periodontitis, type 2 diabetes mellitus | Mahidol University | Unknown | No outcome recorded |
| Phase 2 | NCT03223519 Comparator | Jul → Nov 2017 | — | Spherium Biomed | Completed | No outcome recorded |
| Phase 2 | NCT03106948 Comparator | Feb 2017 → Jan 2018 | vascular occlusion disorder | Southeast Renal Research Institute | Unknown | No outcome recorded |
| Phase 2 | NCT02734147 Comparator | Apr 2016 → Oct 2017 | infectious disease with sepsis | Christiana Care Health Services | Terminated | No outcome recorded Stop: Business |
| Phase 2 | NCT02106975 Comparator | Apr 2014 → Nov 2017 | acute lung injury, infectious disease with sepsis | Virginia Commonwealth University | Completed | No outcome recorded |
| Phase 2 | NCT01587963 Comparator | Feb 2013 → Feb 2014 | — | Rutgers, The State University of New Jersey | Terminated | No outcome recorded |
| Phase 2 | NCT03524846 Comparator | Apr → Oct 2011 | — | National Taiwan University Hospital Hsin-Chu Branch | Completed | No outcome recorded |
| Phase 2/3 | NCT07476443 Comparator | Apr 2026 → May 2027 expected | cisplatin toxicity | Ain Shams University | Not yet recruiting | No outcome recorded |
| Phase 2/3 | NCT05310760 Comparator | Mar → Jul 2022 | rickets | Cairo University | Completed | No outcome recorded |
| Phase 2/3 | NCT03338569 Comparator | Dec 2017 → Jun 2020 | infectious disease with sepsis | University of Minnesota | Completed | No outcome recorded |
| Phase 2/3 | NCT02083575 Comparator | Apr 2014 | beta-thalassemia major | Ain Shams University | Unknown | No outcome recorded |
| Phase 2/3 | NCT00064753 Background | May 2002 → Oct 2011 | cardiovascular disorder, chronic kidney disease | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Completed | Missed primary |
| Phase 3 | NCT07810101 Comparator | Sep 2026 → Feb 2027 expected | gingival disorder | Al-Azhar University | Enrolling by invitation | No outcome recorded |
| Phase 3 | NCT06044194 Comparator | Mar 2023 → Sep 2024 | heart failure | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | Unknown | No outcome recorded |
| Phase 3 | NCT04955145 Comparator | Jun 2021 → Jan 2022 | end stage renal failure | Ain Shams University | Unknown | No outcome recorded |
| Phase 3 | NCT04747795 Comparator | Jun 2021 → Aug 2023 | infectious disease with sepsis | Universitaire Ziekenhuizen KU Leuven | Completed | No outcome recorded |
| Phase 3 | NCT04810728 Background | Jun → Dec 2020 | COVID-19 | Baiturrahmah University | Completed | Met primary |
| Phase 3 | NCT04409483 Background | Jun → Dec 2020 | COVID-19 | Epicentre | Withdrawn | No outcome recorded |
| Phase 3 | NCT04197115 Comparator | Sep 2019 → Aug 2020 | infectious disease with sepsis | IMSS Hospital General de Zona 11, Piedras Negras | Completed | No outcome recorded |
| Phase 3 | NCT01283646 Comparator | Oct 2011 → May 2012 | — | EMS | Completed | No outcome recorded |
| Phase 3 | NCT01295450 Comparator | Apr → Aug 2011 | eating disorder | MDCPharma Produtos Farmaceuticos LTDA | Unknown | No outcome recorded |
| Phase 3 | NCT01266928 Comparator | Jan → Nov 2011 | preterm premature rupture of the membranes | Erzincan Military Hospital | Completed | No outcome recorded |
| Phase 3 | NCT01107730 Comparator | Apr 2010 → Apr 2015 | atrial fibrillation | Attikon Hospital | Completed | No outcome recorded |
| Phase 3 | NCT00953212 Comparator | Aug 2009 → Jan 2012 | atrial fibrillation, atrial flutter | MaineHealth | Completed | No outcome recorded |
| Phase 3 | NCT00631111 Comparator | Nov 2007 → Apr 2008 | — | Wyeth is now a wholly owned subsidiary of Pfizer | Completed | No outcome recorded |
| Phase 4 | NCT07862725 Background | Oct 2026 → Oct 2027 expected | oligoasthenoteratozoospermia | Hamad Medical Corporation | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT06224881 Comparator | Dec 2021 → Jan 2023 | infectious disease with sepsis | Cairo University | Completed | No outcome recorded |
| Phase 4 | NCT06556134 Comparator | Jul 2021 → Jul 2023 | anemia due to chronic disorder | Centre Hospitalier Hassan II - Fès | Completed | No outcome recorded |
| Phase 4 | NCT03830489 Comparator | Feb → Oct 2019 | — | Hospital Universitario de Canarias | Completed | Missed primary |
| Phase 4 | NCT03698474 Comparator | Oct 2018 → Feb 2019 | — | Tomas Bata Hospital, Czech Republic | Completed | No outcome recorded |
| Phase 4 | NCT03581149 Comparator | Mar 2018 → Jul 2020 | ulcerative colitis | American University of Beirut Medical Center | Unknown | No outcome recorded |
| Phase 4 | NCT03188445 Comparator | Jul 2017 → Jun 2020 | iron deficiency anemia | Pharmacosmos A/S | Completed | Met primary |
| Phase 4 | NCT02956057 Comparator | Nov 2016 → May 2017 | — | Tomas Bata Hospital, Czech Republic | Completed | No outcome recorded |
| Phase 4 | NCT02761213 Comparator | Apr 2016 → Aug 2017 | colonic disorder | Bo-In Lee | Completed | Met primary |
| Phase 4 | NCT02639741 Comparator | Nov 2014 → Jan 2020 | — | Cukurova University | Completed | No outcome recorded |
| Phase 4 | NCT02209636 Background | Sep 2014 → Jun 2019 | cardiovascular disorder, chronic kidney disease | VA Office of Research and Development | Completed | Missed primary |
| Phase 4 | NCT01558622 Comparator | Mar → May 2012 | — | Kavaklıdere Umut Hospital | Unknown | No outcome recorded |
| Phase 4 | NCT02780505 Comparator | Nov 2011 → Apr 2012 | anemia | Shiraz University of Medical Sciences | Completed | No outcome recorded |
| Phase 4 | NCT01332578 Background | May → Jun 2011 | common cold, influenza | GlaxoSmithKline | Completed | Met primary |
| Phase 4 | NCT01322061 Comparator | Nov 2010 → Jul 2011 | cholecystitis | American University of Beirut Medical Center | Completed | No outcome recorded |
| Phase 4 | NCT01090895 Comparator | Mar 2010 → Oct 2017 | intermediate coronary syndrome | University of Roma La Sapienza | Unknown | No outcome recorded |
| Phase 4 | NCT02620345 Background | Jan 2010 → Oct 2015 | benign neoplasm of corpus uteri | Trieu, Nguyen Thi, M.D. | Completed | No outcome recorded |
| Phase 4 | NCT00869427 Comparator | Mar 2009 → Jun 2011 | spinal cord injury, urinary tract infection | Sunnaas Rehabilitation Hospital | Terminated | No outcome recorded Stop: Enrollment |
| Phase 4 | NCT00519337 Comparator | Oct 2008 → Oct 2009 | — | Hartford Hospital | Completed | No outcome recorded |
| Phase 4 | NCT01167569 Comparator | Oct 2007 → Apr 2013 | — | Rutgers, The State University of New Jersey | Completed | No outcome recorded |
| Phase 4 | NCT00431691 Comparator | Sep 2006 → Dec 2007 | escherichia coli infection, retinal disorder | Medical University of Vienna | Completed | No outcome recorded |
| Phase 4 | NCT01033526 Background | Oct 2005 → Jun 2007 | common cold | Bayer | Completed | No outcome recorded |
| — | NCT07366502 Comparator | Sep 2025 → Jul 2026 overdue | disorder of iron metabolism and transport, iron deficiency anemia | Medeni Şermet | Recruiting | No outcome recorded |
| — | NCT06936592 Comparator | Apr → Oct 2025 overdue | gingival recession | Minia University | Not yet recruiting | No outcome recorded |
| — | NCT06597682 Background | Mar 2025 → Jul 2027 expected | long COVID-19 | Huashan Hospital | Not yet recruiting | No outcome recorded |
| — | NCT06749756 Comparator | Feb 2025 → Feb 2026 overdue | infectious disease with sepsis | Fan Zeng | Recruiting | No outcome recorded |
| — | NCT06374771 Comparator | Apr → Jun 2024 | — | Cairo University | Unknown | No outcome recorded |
| — | NCT06009744 Comparator | Aug 2023 → Dec 2028 expected | intestinal fistula | Hospital Juarez de Mexico | Recruiting | No outcome recorded |
| — | NCT05977166 Comparator | Mar → Jun 2022 | long COVID-19 | Cairo University | Completed | No outcome recorded |
| — | NCT05930002 Comparator | Jul 2021 → Sep 2022 | COVID-19 | Ain Shams University | Completed | No outcome recorded |
| — | NCT04682574 Comparator | Nov 2020 → Feb 2022 | COVID-19 | University of Lahore | Completed | No outcome recorded |
| — | NCT04216459 Comparator | Feb → Nov 2020 | infectious disease with sepsis | Mansoura University | Completed | No outcome recorded |
| — | NCT04463459 Comparator | Oct 2019 → Jul 2020 | breast cancer | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | Unknown | No outcome recorded |
| — | NCT03391830 Comparator | Jan 2018 → Jan 2020 | acute kidney injury | Mansoura University | Completed | No outcome recorded |
| — | NCT03258684 Comparator | Sep 2017 → Feb 2019 | infectious disease with sepsis | Zhujiang Hospital | Completed | No outcome recorded |
| — | NCT03218280 Comparator | Jan 2017 → Nov 2019 | — | Romanian Society of Anesthesia and Intensive Care | Unknown | No outcome recorded |
| — | NCT03659058 Comparator | Mar 2016 → Aug 2018 | fibrotic liver disease | Zagazig University | Completed | No outcome recorded |
| — | NCT02799134 Comparator | Nov 2015 → Apr 2017 | — | qinshaozheng | Completed | No outcome recorded |
| — | NCT03260829 Comparator | Jan 2014 → Jan 2015 | impacted teeth, multiple | Cairo University | Completed | No outcome recorded |
| — | NCT00914576 Comparator | Apr 2011 → Jul 2013 | — | Medical University of Vienna | Completed | No outcome recorded |
| — | NCT00845130 Background | Sep 2009 → Dec 2014 | disorder of defective peroxisome oxidative status, type 2 diabetes mellitus | In-Young Choi, Ph.D. | Completed | No outcome recorded |
| — | NCT00893724 Comparator | Jun 2009 → Aug 2011 | diabetic macular edema, wet macular degeneration | Mid-Atlantic Retina Consultations, Inc. | Unknown | No outcome recorded |
| — | NCT00889538 Comparator | Apr 2009 → Sep 2012 | autism, disruptive behavior disorder | University of Louisville | Completed | No outcome recorded |
| — | NCT00624871 Comparator | Apr 2004 → Apr 2006 | brain hypoxia - ischemia, perinatal asphyxia | Al-Azhar University | Completed | No outcome recorded |
News releases announcing trial results or a regulatory action · 3
| Date | Issuer | Release |
|---|---|---|
| 2018-02-22 | Norgine | Results Positive new data show superiority of PLENVU® (1 LITRE PEG preparation) compared to MOVIPREP® (2 LITRE PEG + ASCORBATE) norgine.com ↗ |
| 2017-10-18 | McGuff Pharmaceuticals, Inc. | Regulatory McGuff Pharmaceuticals Inc. announces the Food and Drug Administration’s New Drug Approval of Ascor® Ascorbic Acid Injection, USP mcguffpharmaceuticals.com ↗ |
| 2009-02-03 | BioMarin Pharmaceutical | Results Results From Phase 2 Clinical Study of 6R-BH4 in Peripheral Arterial Disease Not Statistically Significant biomarin.com ↗
Addition of Vitamin C to 6R-BH4 did not improve efficacy on PWT. |
All press releases naming this drug 7 releases
Evidence & citations 26 cited values
Every value below carries the sentence it was read from. 383 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Vitamin C | “The aim of this trial is to investigate whether the combined use of cortisol, ascorbic acid (vitamin C), and thiamine during the early post-resuscitation period reduces the...” PMID 40215244 ↗ Apr 2025239“Preclinical studies of pharmacologic doses of vitamin C (ascorbic acid, ascorbate) have shown significant anticancer effects in animal models and tissue culture investigations...” NCT00441207 ↗ “with daily multivitamins [vitamin A (300 microg, as retinol palmitate), vitamin E (6 mg tocopherol equivalents), vitamin B-12 (0.9 microg), vitamin C (15 mg), riboflavin (0.5...” PMID 19535425 ↗ Jun 2009 “This standard treatment is personalized according to the severity but is not limited to standard antiviral therapy, azithromycin 500 mg a day, vitamin C 500 mg 8 hourly a day,...” NCT05398965 ↗ “Vitamin C (1,000 mg i.v.) and Vitamin E (1,000 IU p.o. via the naso-gastric tube) administered every 8 hours starting within one hour after admission to the Emergency...” NCT01897792 ↗ “total daily dose label claim: micronutrient combination of 500 mg vitamin C (magnesium ascorbate), 315 mg magnesium (magnesium citrate, magnesium ascorbate, magnesium...” NCT00808470 ↗ “This feasibility study serves to determine if it is possible to perform a powered randomized control trial of high-dose intravenous vitamin C (ascorbic acid) as an adjunctive...” NCT04088591 ↗ “It consists in a tablet with lutein (10 mg), astaxanthin (4 mg), Zeaxanthin (1mg), vitamin C (L-ascorbic acid 180mg), vitamin E (DL-alpha tocopherol 30mg), zinc (zinc oxide...” NCT03702374 ↗ “food supplement containing 2000 mg L-carnitine, 2000 mg fructose, 932 mg acetyl L-carnitine, 225 mg vitamin C, 115 mg citric acid, 50 mg coenzyme Q10, 14 mg zinc, 115 µg...” NCT06042738 ↗ “The antioxidants are ascorbic acid (vitamin C) 3 grams intravenously preoperatively and N-acetylcysteine 100 milligrams/kilogram body weight intravenous infusion for 4 hours,...” NCT03494387 ↗ “Vitamin C, known as ascorbic acid, is used as a treatment modality in depigmentation of hyperpigmented spots on the skin and gingiva by inhibition of tyrosinase enzyme causing...” NCT07810101 ↗ |
| Known as | ASC | “ARINA-1 (88 mg/mL ascorbic acid, ASC; 150 mg/mL reduced glutathione, GSH)” NCT05654922 ↗1“ARINA-1 (88 mg/mL ascorbic acid, ASC; 150 mg/mL reduced glutathione, GSH)” NCT05495243 ↗ |
| Known as | ASCOR | “(ASCOR) will be obtained from the KU Investigational Pharmacy located in the KU Clinical Research Center where studies will take place. A priming bolus of 0.06 g ascorbic...” NCT04832009 ↗ |
| Known as | Ascor L 500 | “Ascor L 500® (Ascorbic Acid Injection, USP)” NCT02534753 ↗ |
| Known as | ascorbate | “Preclinical studies of pharmacologic doses of vitamin C (ascorbic acid, ascorbate) have shown significant anticancer effects in animal models and tissue culture investigations...” NCT00441207 ↗5“There is increasing interest in using high-dose intravenous ascorbate (IVC) in treating this disease partially because of its low toxicity.” PMID 29215048 ↗ Dec 2017 “Intravenous ascorbate (i.e., ascorbic acid, vitamin C), but not oral ascorbate, produces high plasma concentrations” NCT01515046 ↗ “Vitamin C, also called ascorbate, is an essential nutrient for the human body.” NCT06598033 ↗ “Vitamin C, also called ascorbate, is an essential nutrient for the human body.” NCT06601283 ↗ “Ascorbate” NCT01555489 ↗ |
| Known as | ascorbic acid | “Eligible subjects with NPM1 MRD positivity will receive oral arsenic trioxide (oral-As2O3) (Arsenol ®) (5-10mg per day, from days 1-7 per cycle), ascorbic acid (1g per day,...” NCT04689815 ↗193“The present randomized controlled study was conducted in 28 patients and aimed to investigate the potential nephroprotective effect of intravenous ascorbic acid (2 g every 12...” PMID 25801556 ↗ Mar 2015 “Hospitalized adult patients were randomized to receive low volume (2 L polyethylene glycol and ascorbic acid, 2L PEG+ASC) or standard volume bowel preparation (4 L polyethylene...” PMID 41128725 ↗ Oct 2025 “Apevinat BC presents in its formula the cyproheptadine hydrochloride (0,800 mg), tiamin hydrochloride(0,120 mg), Riboflavin sodium phosphate (0,200 mg), nicotinamide (1,334 mg,...” NCT01295450 ↗ “The antioxidants are ascorbic acid (vitamin C) 3 grams intravenously preoperatively and N-acetylcysteine 100 milligrams/kilogram body weight intravenous infusion for 4 hours,...” NCT03494387 ↗ “Subjects will be asked to take 1L of PEG-3350 containing ascorbic acid solution the day prior to procedure, followed by another 1L of PEG-3350 containing ascorbic acid solution...” NCT02290093 ↗ “Anti-oxidants such as N-acetylcysteine (NAc), Vitamin C (ascorbic acid) (VitC) and Vitamin E (alpha-tocopherol) (VitE) are potent FRS 'scavengers', which means they could be...” NCT02629536 ↗ “Active drug comprised of: ascorbic acid, magnesium sulfate heptahydrate, cyanocobalamin, thiamine, riboflavin 5' phosphate, niacinamide, pyridoxine, calcium d-pantothenate, and...” NCT04708340 ↗ “Vitamin C (ascorbic acid) is water-soluble, found throughout the body and is especially highly concentrated in the brain, which has antioxidant and neuroprotective properties.” NCT02127060 ↗ “Induction consisted of up to eight 28-d cycles of bortezomib 1.0 mg/m(2) on days 1, 4, 8 and 11, plus oral ascorbic acid 1 g and oral melphalan 0.1 mg/kg on days 1-4” PMID 19226361 ↗ Feb 2009 “To determine whether regulating vitamin C (ascorbic acid: AA) intake to achieve higher or lower plasma concentrations was associated with improved clinical outcome.” PMID 15724034 ↗ Mar 2005 |
| Known as | ascorbic complex | “The 130 subjects will be randomized into 3 groups: Experimental group 1 will receive a supplement of vitamin C (ascorbic complex) of the Bonusan brand, a daily dose of 1000mg...” NCT04445727 ↗ |
| Known as | ascorbinezuur | “Vitamine C will be administered intravenously as ascorbic acid (ascorbinezuur CF 100 mg/ml, Centrafarm BV, Etten Leur, Netherlands).” NCT03509662 ↗ |
| Known as | Bonusan | “The 130 subjects will be randomized into 3 groups: Experimental group 1 will receive a supplement of vitamin C (ascorbic complex) of the Bonusan brand, a daily dose of 1000mg...” NCT04445727 ↗ |
| Known as | CA201A | “This is a multicenter, randomized, double-masked, vehicle-controlled, parallel-arm, Phase 2 study designed to evaluate the safety and efficacy of CA201A, a 5% ascorbic acid...” NCT07694375 ↗ |
| Known as | Cebionâ 1000 per 2/die | “daily 2 g ascorbic acid (Cebionâ 1000 per 2/die) supplementation” NCT00387114 ↗ |
| Known as | E 300 | “Active substance: Ascorbic acid (Vitamin C, E 300).” NCT04472000 ↗ |
| Known as | HDAA | “High Dose Ascorbic Acid (HDAA) in Patients With Plasma Cell Disorders” NCT06313502 ↗ |
| Known as | High Dose Ascorbic Acid | “High Dose Ascorbic Acid (HDAA) in Patients With Plasma Cell Disorders” NCT06313502 ↗ |
| Known as | IVC | “There is increasing interest in using high-dose intravenous ascorbate (IVC) in treating this disease partially because of its low toxicity.” PMID 29215048 ↗ Dec 20172“high dose intravenous vitamin C (IVC) therapy plus very low carbohydrate diet (VLCD) for stage IV colon cancer” NCT04035096 ↗ “Week 1: 2 visits for escalating doses of intravenous ascorbic acid (IV C).” NCT01364805 ↗ |
| Known as | L-ascorbic acid | “It consists in a tablet with lutein (10 mg), astaxanthin (4 mg), Zeaxanthin (1mg), vitamin C (L-ascorbic acid 180mg), vitamin E (DL-alpha tocopherol 30mg), zinc (zinc oxide...” NCT03702374 ↗2“Vitamin C (VC), also known as L-ascorbic acid, has been shown to have antimicrobial and immunomodulatory properties.” PMID 32641343 ↗ Jul 2020 “vitamin C (L-ascorbic acid 180 mg)” NCT04071977 ↗ |
| Known as | Laroscorbine | “Vitamin C (Laroscorbine) + Vitamin B1 (Bevitine)” NCT05817851 ↗ |
| Known as | Moviprep | “Polyethylene glycol / Ascorbic acid ( Moviprep™, oral solution) 2L in the evening before colonoscopy” NCT03698474 ↗ |
| Known as | My Immuno | “Vitamin C (My Immuno) 1 scoop per day” NCT04693936 ↗ |
| Known as | P-AscH- | “PURPOSE: Pharmacologic ascorbate (P-AscH-) is hypothesized to be an iron (Fe)-dependent tumor-specific adjuvant to chemoradiation in treating glioblastoma (GBM).” PMID 37773633 ↗ Jan 2024 |
| Known as | pharmacological ascorbate | “Treatment for pancreatic cancer with pharmacological ascorbate (ascorbic acid, vitamin C) decreases tumor progression in preclinical models.” PMID 23381814 ↗ Feb 2013 |
| Known as | polyethylene glycol + ascorbic acid | “Patients will receive 2L polyethylene glycol + ascorbic acid (MoviPrep®) solution with an instruction leaflet.” NCT03581149 ↗ |
| Known as | vit-C | “Anti-oxidants such as N-acetylcysteine (NAc), Vitamin C (ascorbic acid) (VitC) and Vitamin E (alpha-tocopherol) (VitE) are potent FRS 'scavengers', which means they could be...” NCT02629536 ↗5“Group 1 received vitamin C (Vit C), Group 2 vitamin E (Vit E), Group 3 n-acetylcysteine (NAC), Group 4 melatonin (MT) and group 5 no treatment.” PMID 37174730 ↗ May 2023 “The aim of this study is to assess the ability of high-dose intravenous vitamin C (Vit-C) to improve post-CA shock.” PMID 39317492 ↗ Sep 2024 “Ascorbic Acid (Vit C)- 1000 mg IVPB after Arsenic Trioxide \[ATO\] days 1, 4, 8, 11” NCT00258245 ↗ |
| Action | Inhibit | “Ascorbic acid has the ability to inhibit peroxidase and may thus inhibit melanin synthesis.” NCT00172302 ↗ |
| Modality | Other / unclassified | “antioxidant supplementation with vitamins C and E” PMID 20375405 ↗ Apr 2010 |
| Route | Oral | “Oral Vitamin C” NCT00001070 ↗ |